Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OLMA

Olema Pharmaceuticals (OLMA)

Olema Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OLMA
DateTimeSourceHeadlineSymbolCompany
11/30/20217:00AMGlobeNewswire Inc.Olema Oncology Announces First Clinical Data on OP-1250 in Advanced ER+ / HER2- Breast CancerNASDAQ:OLMAOlema Pharmaceuticals Inc
11/29/20214:27PMGlobeNewswire Inc.Olema Oncology Issues Statement Regarding Falsified Information Circulating on Social MediaNASDAQ:OLMAOlema Pharmaceuticals Inc
11/22/20217:30AMGlobeNewswire Inc.Olema Oncology to Present New Data on OP-1250 at 2021 San Antonio Breast Cancer SymposiumNASDAQ:OLMAOlema Pharmaceuticals Inc
11/10/20214:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
11/10/20214:05PMGlobeNewswire Inc.Olema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:OLMAOlema Pharmaceuticals Inc
11/09/20217:30AMGlobeNewswire Inc.Olema Oncology to Present at Two Upcoming Investor ConferencesNASDAQ:OLMAOlema Pharmaceuticals Inc
10/21/20214:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
10/12/20216:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
09/30/20215:00PMGlobeNewswire Inc.Olema Oncology Announces Trials in Progress Poster on OP-1250 at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:OLMAOlema Pharmaceuticals Inc
09/21/20216:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
09/09/20214:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
09/09/20217:30AMGlobeNewswire Inc.Olema Oncology to Present Data on OP-1250 at the 2021 JCA-AACR Precision Cancer Medicine International ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
09/03/20215:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
08/30/20214:05PMGlobeNewswire Inc.Olema Oncology to Present at Morgan Stanley 19th Annual Global Healthcare ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
08/11/20216:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
08/10/20214:19PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OLMAOlema Pharmaceuticals Inc
08/10/20214:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
08/10/20214:05PMGlobeNewswire Inc.Olema Oncology Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:OLMAOlema Pharmaceuticals Inc
07/28/20214:05PMGlobeNewswire Inc.Olema Oncology to Present at Canaccord Genuity 41st Annual Growth ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
07/21/20215:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
07/13/20216:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/10/20216:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/10/20216:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/10/20216:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/10/20216:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OLMAOlema Pharmaceuticals Inc
06/09/20214:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/18/20214:05PMGlobeNewswire Inc.Olema Oncology to Participate at the Jefferies 2021 Virtual Healthcare ConferenceNASDAQ:OLMAOlema Pharmaceuticals Inc
05/11/20214:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OLMAOlema Pharmaceuticals Inc
05/11/20214:05PMGlobeNewswire Inc.Olema Oncology Reports First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:OLMAOlema Pharmaceuticals Inc
04/27/20214:12PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OLMAOlema Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:OLMA